Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been a favourite of cannabis investors since 2016. Over the past three years, shares have increased in value by more than 3,000%. Now with a market cap of $12 billion, Aurora is a cannabis giant. If you think that shares will continue higher, however, be cautious. Here’s why now is not the time to buy stock…
Read MoreKali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) announced today that its Hemp4mula CBD gum is now available for sale on line at USMJ.com. KALY acquired a patented cannabis extraction process in the fourth quarter of 2019 and has rapidly implemented a multitiered strategy to monetize the value of the patented process. The company has recently announced a $300,000 order…
Read More
Canopy Growth (TSX:WEED)(NYSE:CGC) has historically been very cautious when it comes to its investment in cannabis south of the border. This cautiousness was vindicated when companies like Aphria faced the possibility of de-listing on the TSX due to its cannabis investment in the U.S., where the substance is still under a federal ban. Many voices in the U.S. are now…
Read More
When a stock is oversold it could be a great time for investors to buy at a reduced price. Whether it’s a result of bad press, disappointing earnings, or nothing apparent at all, an oversold stock is one that sometimes can be due to bounce back as a result of excessive negativity. Below are two stocks that look like they…
Read More
Last week, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) announced the biggest deal we’ve seen in the cannabis industry thus far – a US$3.4 billion acquisition of Acreage Holdings Inc. (CNSX:ACRG.U). Although it’s a significant transaction for Canopy Growth that would make it a big player in the U.S. overnight, it may take a while before we see the deal finalized, as there is one…
Read More
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) was rallying almost 10% at the time of writing last Thursday, the day of the announcement of its plan to acquire leading U.S. cannabis operator, Acreage Holdings. In an attempt to keep its first mover advantage and extend it to the U.S., Canopy Growth has made this unprecedented move to acquire “at such time as cannabis…
Read More
Nothing earthshaking happened when Aphria (TSX:APHA)(NYSE:APHA) reported its latest quarterly earnings, except for the sharp drop in the stock price. That pattern has been same whenever cannabis producers present their earnings results. Every story is predictable — whopping revenues and a mountain of losses. For the first time, Aphria’s earnings results included a full quarter of adult-use sales. APHA sunk…
Read More
This week, Aphria (TSX:APHA)(NYSE:APHA) reported its earnings and analysts were more than shocked at the results. It was a massive letdown for shareholders who had high hopes for the cannabis company. Aphria remains in third place among Canadian marijuana companies, but now some are worrying that it won’t keep that spot for long. Then we have Aurora Cannabis (TSX:ACB)(NYSE:ACB). This company…
Read More
The battle for supremacy in the cannabis space is getting furious as the months roll on. So far this year, Aurora Cannabis (TSX:ACB)(NYSE:ACB) seems to be steamrolling to greater success. Canopy Growth (TSX:WEED)(NYSE:CGC) has the upper hand in terms of market cap but is lagging behind in performance. Aurora Cannabis only has an individual strategic advisor to fight the battle…
Read More
In April, Aphria (TSX:APHA)(NYSE:APHA) became the first cannabis company to report quarterly earnings for 2019. Because the company’s fiscal year ends in the summer, the announcement was technically Aphria’s third-quarter result of FY 2019. The stock market was not impressed. According to Fool contributor Keith Speights, several factors were to blame. First, Aphria was having trouble keeping up with demand.…
Read More